Walleye Trading’s Cytosorbents Corp CTSO Stock Holding History

Walleye Trading’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,402	Closed	-$201K	–	5412
2021 Q4	$201K	Buy	+2,402	New	+$270K	﹤0.01%	3854

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Walleye Trading's CTSO Position: Q1 2022 in Review

Walleye Trading sold out of Cytosorbents Corp (CTSO) in Q1 2022, closing a stake of 2,402 shares — an estimated $201K sold.

Walleye Trading first reported a position in CTSO in Q4 2021 and held it in 1 quarter. The position peaked at $201K in Q4 2021. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

Walleye Trading reported no remaining Cytosorbents Corp position as of Q1 2022 after selling out during the quarter.
Walleye Trading sold 2,402 Cytosorbents Corp shares in Q1 2022, an estimated $201K.
Walleye Trading first reported a position in Cytosorbents Corp in Q4 2021 and held it in 1 quarter.
Walleye Trading's Cytosorbents Corp position peaked at $201K in Q4 2021.
88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.